GlassScriptPhysician profile
Andrew Franklin
NPI 1285996140
$4,737.58
in general payments reported to CMS, 2019-2025
42 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $855 · 2021: $725 · 2022: $784 · 2023: $1,474 · 2024: $496 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,696 · Travel and Lodging: $394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,695.73 |
| Travel and Lodging | $394.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $937.13 | 2019-2024 | Rezum Generator, Ams 700 |
| Medtronic, INC. | $609.85 | 2021-2025 | Interstim |
| Pfizer INC. | $385.90 | 2019-2024 | |
| Abbvie INC. | $328.57 | 2019-2024 | |
| Endo Pharmaceuticals INC. | $327.58 | 2020-2024 | Aveed, Xiaflex |
| Urogen Pharma, INC. | $260.09 | 2020-2024 | Jelmyto |
| Teleflex LLC | $216.79 | 2021-2024 | Urolift |
| Medtronic USA, INC. | $184.30 | 2020 | |
| Janssen Biotech, INC. | $169.36 | 2021-2024 | Erleada |
| Astellas Pharma US INC | $145.33 | 2019-2025 | Xtandi |
| Neotract INC. | $139.87 | 2020 | |
| Sumitomo Pharma America, INC. | $90.39 | 2023-2025 | Gemtesa, Orgovyx |
| C. R. Bard, INC. & Subsidiaries | $75.67 | 2023 | Bard Urinary Drainage Bag |
| Olympus America INC. | $71.27 | 2019-2023 | Itind System |
| Endo USA, INC. | $62.58 | 2024 | Xiaflex, Aveed |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Franklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.